Effects of long term used inhaled corticosteroids on growth and bone mineral density in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
The influence of inhalation thechnics at the long application of high dose inhaled corticosteroids on the mineral bone density (MBD) in children Source: Eur Respir J 2004; 24: Suppl. 48, 133s Year: 2004
Long-term effects of corticosteroid use on bone mineral density in asthmatic children Source: Breathe 2008; 5: 70-71 Year: 2008
Continuity study of the bone mineral density reduction in long term use of inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015
Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Bone mineral density and inhaled budesonide – a systematic review of long-term treatment in children and adults Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005
Peak bone mineral density (BMD) in children with asthma treated for a mean of 14 years with inhaled budesonide Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Lack of association between inhaled corticosteroids and bone density in postmenopausal women Source: Eur Respir J 2001; 18: Suppl. 33, 442s Year: 2001
Morning cortizolemia and bone status during long term therapy with inhaled steroids in children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Effect of inhaled fluticasone poprionate and repeated short courses of oral corticosteroid on bone turnover in asthmatic children Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002
Bone mineral density is related to exercise capacity in COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005
The association between inhaled corticosteroid and osteoporosis and fracture Source: Eur Respir J, 57 (6) 2100216; 10.1183/13993003.00216-2021 Year: 2021
Inhaled corticosteroids and bone mineral density in children: A prospective 12-year follow-up study after early-life wheezing Source: Annual Congress 2012 - Treating childhood asthma Year: 2012
Bone mineral density and calciun metabolism in sarcoidosis at clinical onset Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004
Bone mineral density in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005
Apparent high prevalence of reduced bone mineral density in an adolescent asthma clinic Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
Inhaled corticosteroids (ICS) and bone mineral density (BMD) - a follow-up study. The bronchial obstruction in Nord-Trøndelag study (BONT) Source: Eur Respir J 2004; 24: Suppl. 48, 601s Year: 2004